During the past decade, Weill Cornell Breast Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Weill Cornell Breast Center" #1 sponsor was "Eisai Inc." with 2 trials, followed by "Clovis Oncology, Inc." with 1 trials sponsored, "Incyte Corporation" with 1 trials sponsored, "Infinity Pharmaceuticals, Inc." with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Weill Cornell Breast Center" #1 collaborator was "Eisai Limited" with 2 trials as a collaborator and "Medivation, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Weill Cornell Breast Center" are "Breast Cancer" (6 trials), "Metastatic Breast Cancer" (3 trials), "BRCA 1 Gene Mutation" (1 trials), "BRCA 2 Gene Mutation" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Weill Cornell Breast Center" in a lesser frequency.

Most popular intervention types in "Weill Cornell Breast Center" are "Drug" (7 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "E7389" (2 trials), "Dignicap System" (1 trials), "INCB0123667" (1 trials), "IPI-504" (1 trials) and "Infrared Breast Scan" (1 trials). Other intervention names were less common.

The vast majority of trials in "Weill Cornell Breast Center" are 5 trials for "Female" genders and 4 trials for "All" genders.

Currently, there are NaN active trials in "Weill Cornell Breast Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Weill Cornell Breast Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Weill Cornell Breast Center, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".